Manufacturer of SARS-CoV-2 antibody - Aspergillus Galactomannan Detection Kit (CLIA) – Genobio

Product Introduction

This product is a chemiluminescence immunoassay used for the quantitative detection of the Aspergillus galactomannan in human serum and bronchoalveolar lavage (BAL) fluid.

The incidence of Invasive Aspergillosis (IA) in immunosuppressed patients is rapidly increasing due to antibiotic abuse. Aspergillus fumigatus is one of the most common pathogens that cause severe aspergillus infection in patients with immunosuppressive disease, followed by Aspergillus flavus, Aspergillus niger and Aspergillus terreus. Due to lack of typical clinical manifestations and effective early diagnosis methods, IA has a high mortality rate of 60% to 100%.

FungiXpert® Aspergillus Galactomannan Detection Kit (CLIA) is the world’s first and only quantitative reagent for the early detection of invasive Aspergillus infection with chemiluminescence integrated reagent strip. It is fully automated with FACIS to complete sample pretreatment and experimental testing, fully liberating the hands of laboratory physician and greatly improve detection accuracy.

Characteristics

Advantages

• Used with FACIS – Rapid and easy!
  Obtain results within 40-60 min
  Total on-screen instruction with FACIS intelligent software

• Independent design brings convenience!
  All-in-one reagent strip cartridge – integrates reagents and consumables together, special design to perfectly fit FACIS
  Unique sample pretreatment system – micron film with invention patent

• Customer service
  Online training and Q&A
  Free software updating service
  More FACIS CLIA reagents available

Related videos

Order Information